Hunkapiller Leaves as ABI Prepares For Phase Three and a Fuzzy Future | GenomeWeb

In one of his last public statements as president of Applied Biosystems, Mike Hunkapiller wrapped up a presentation on ABI’s finances in July by identifying two important trends in life sciences research.

“The first is the trend to systems biology, or integrated science, and the second is the trend towards targeted medicine,” Hunkapiller said. “At Applied Biosystems, we need to ensure that we continue to introduce products that support these research trends.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.